Cargando…
Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic
BACKGROUND: To ensure safe delivery of oncologic care during the COVID-19 pandemic, telemedicine has been rapidly adopted. However, little data exist on the impact of telemedicine on quality and accessibility of oncologic care. This study assessed whether conducting an office visit for thoracic onco...
Autores principales: | Nimgaonkar, Vivek, Aggarwal, Charu, Berman, Abigail T., Gabriel, Peter, Shulman, Lawrence N., Kucharczuk, John, Roy, Megan, Bauml, Joshua M., Singh, Aditi P., Cohen, Roger B., Langer, Corey J., Marmarelis, Melina E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503709/ https://www.ncbi.nlm.nih.gov/pubmed/34635061 http://dx.doi.org/10.1186/s12885-021-08819-z |
Ejemplares similares
-
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC—Results From a Prospective Pilot Study
por: Thompson, Jeffrey C., et al.
Publicado: (2022) -
A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer
por: Aggarwal, Charu, et al.
Publicado: (2023) -
Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapy
por: Brady, Anna K., et al.
Publicado: (2015) -
Adoption of routine telemedicine in Norway: the current picture
por: Zanaboni, Paolo, et al.
Publicado: (2014) -
Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: A review of the National Cancer Database
por: Bou‐Samra, Patrick, et al.
Publicado: (2023)